← Eichor
Study identifier: NCT06775769 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Endometrioma Sclerotherapy and Ovarian Preservation

Condition: Endometrioma  ·  Sponsor: Chelsea and Westminster NHS Foundation Trust

PhaseNA
Planned participants60
Who can joinFemale, 18 Years to 45 Years
Healthy volunteersNo

About this study

A randomised controlled trial assessing ovarian reserve after laparoscopic ethanol sclerotherapy of ovarian endometrioma compared to standard treatment of surgical excision of endometrioma. Secondary outcomes will include endometrioma recurrence, symptomatology and inflammatory environment.

This description comes directly from the study's public registry record.

Talk to the study team

Sarah Bennet, BSc MBBS MRCOG  ·  07983980924  ·  sarah.bennet25@imperial.ac.uk

Thomas Bainton, BM BCh MRCOG MA(Oxon)  ·  tombainton@doctors.org.uk

Always discuss trial participation with your own doctor first.

Locations (1)

Chelsea and Westminster NHS Foundation TrustLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06775769